Survival impact of early MRI progression after stereotactic radiotherapy for brain metastases

Moncef Morjani; Brieg Dissaux; Victor Nguyen; Gurvan Dissaux; Olivier Pradier; Solène Querellou; Romuald Seizeur; Ulrike Schick; François Lucia; Vincent Bourbonne

doi:10.1002/cac2.12641

Cancer Communications ›› 2025, Vol. 45 ›› Issue (3) : 215 -217. DOI: 10.1002/cac2.12641

LETTER TO THE JOURNAL

Survival impact of early MRI progression after stereotactic radiotherapy for brain metastases

Author information +

History +

PDF

Cite this article

Download citation ▾

Moncef Morjani, Brieg Dissaux, Victor Nguyen, Gurvan Dissaux, Olivier Pradier, Solène Querellou, Romuald Seizeur, Ulrike Schick, François Lucia, Vincent Bourbonne. Survival impact of early MRI progression after stereotactic radiotherapy for brain metastases. Cancer Communications, 2025, 45(3): 215-217 DOI:10.1002/cac2.12641

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Dhermain F, Noel G, Antoni D, Tallet A. Role of radiation therapy in brain metastases management. Cancer Radiother. 2020; 24(6-7): 463-9.

[2]	Narita Y, Sato S, Kayama T. Review of the diagnosis and treatment of brain metastases. Jpn J Clin Oncol. 2022; 52(1): 3-7.

[3]	Bachmann N, Leiser D, Ermis E, Vulcu S, Schucht P, Raabe A, et al. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases. Radiat Oncol. 2019; 14(1): 45.

[4]	Sahgal A, Kellett S, Ruschin M, Greenspoon J, Follwell M, Sinclair J, et al. A Cancer Care Ontario Organizational Guideline for the Delivery of Stereotactic Radiosurgery for Brain Metastasis in Ontario, Canada. Pract Radiat Oncol. 2020; 10(4): 243-54.

[5]	Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2022; 40(5): 492-516.

[6]	Le Rhun E, Dhermain F, Noel G, Reyns N, Carpentier A, Mandonnet E, et al. [ANOCEF guidelines for the management of brain metastases]. Cancer Radiother. 2015; 19(1): 66-71.

[7]	Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003; 3(6): 453-8.

[8]	Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol. 2003; 61(1): 73-80.